skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration

Refine Results

Clear All

Specialism

Show More

Resources

Show More

Show More

Products

Show More

Show More

85 Total results for product and free and sample content found

In Vivo, Citeline

Pipeline-In-A-Pill: Still A Winning Strategy?

Pipeline-In-A-Pill: Still A Winning Strategy?

“Pipeline-in-a-pill” has increasingly entered the biopharma executive’s vernacular, denoting an attractive asset that has considerable sales potential owing to the number of discrete patient populations it can target. While the phrase or concept may be in vogue, in reality it is one of the many guises or iterations of lifecycle management.

Topic BioPharmaceutical Drug Pricing Drug Review Drug Development Landscape

Citeline, In Vivo

Pharma R&D’s COVID-19 Scar

Pharma R&D’s COVID-19 Scar

Months of pandemic-induced disruption to health care systems and freedom of movement undoubtedly carries a cost. For the biopharmaceutical industry, this can be mitigated by its essential role in providing therapeutic interventions and leading the fightback via prophylactic vaccines. This softens the blow somewhat, certainly compared to other industries that are fully exposed to COVID-19 headwinds.

Topic Coronavirus Research & Development

Informatics Solutions

How pharma and biotech are using AI and advanced analytics to deliver successful outcomes

How pharma and biotech are using AI and advanced analytics to deliver successful outcomes

AI applications are as varied as the industry sectors that use them, and pharma has discovered the specific types of AI most useful in achieving faster, more positive results across a wide range of industry activities. 

Informatics Solutions

Big Data's Big Challenge

Big Data's Big Challenge

Pharmaceutical industry experts agree that the future of pharma depends on the use of Big Data to predict upcoming events and markets, gain insights into new opportunities, and understand the implications of competitors’ activities.  

Strategic Transactions

2019 IPOs Startup Firms Grab Nearly One-Third Of Total Proceeds

Medtech_Insight_CMS_Weighs_Merits_Of_New_Pass_Through_Payments_For_Aquabeam_System_Eluvia_Stents_In_OPPS_Proposal

Last year, a total of 67 biopharma and medtech companies completed initial public offerings (IPOs), raising for $8.55bn combined.

Datamonitor Healthcare, Scrip, Trialtrove, In...

The tumor-agnostic developer’s toolkit

The tumor-agnostic developer’s toolkit

The tumor-agnostic developer’s toolkit

Datamonitor Healthcare, Biomedtracker, Pharma...

RNA Targeting Poised To Share The Spotlight With Gene Therapy

Blog

As the biopharma industry concludes its annual pilgrimage to San Francisco for the JP Morgan investor conference, much of the talk around town inevitably was about gene therapies.

Topic Cell and gene therapy

Datamonitor Healthcare, Biomedtracker

Pricing and reimbursement of curative therapies continues to dominate ISPOR discussions

Pricing and reimbursement of curative therapies continues to dominate ISPOR discussions

Commentators at the ISPOR Europe 2019 conference in Copenhagen debated the challenges that exist with valuing and financing potentially curative treatments, including cell and gene therapies, and cancer immunotherapies. With several recent regulatory approvals of high-cost advanced therapy medicinal products (ATMPs), discussion has ensued in earnest on how to determine their clinical value, and whether traditional reimbursement and health technology assessment (HTA) processes are sufficient to assess these innovative treatments.

Citeline

Rescuing The Opioid Crisis

Blog

Recent news of the Ohio State ruling on the opioid litigation trial against Johnson & Johnson shed new light on the complex opioid addiction crisis in the US.

Topic Drug development landscape

Next steps

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Our team is always happy to hear from you. Please call us at:

  • US Toll-Free  : +1 888 670 8900
  • US Toll           : +1 908 547 2200
  • UK & Europe : +44 (20) 337 73737
  • Australia        : +61 2 8705 6907
  • Japan              : +81 3 6273 4260

Or please submit your inquiry via the form so that we can provide you the best possible customer service.

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: